inositol myo-inositol
Selected indexed studies
- Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review. (Nutrients, 2023) [PMID:37111094]
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome. (Gynecol Endocrinol, 2024) [PMID:38239032]
- Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies. (Reprod Health, 2021) [PMID:33468143]
_Worker-drafted node — pending editorial review._
Connections
inositol myo-inositol helps
Sources
- Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review. (2023) pubmed
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome. (2024) pubmed
- Desymmetrization of myo-inositol. (2025) pubmed
- Myo-inositol: a potential prophylaxis against premature onset of labour and preterm birth. (2023) pubmed
- From Myo-inositol to D-chiro-inositol molecular pathways. (2021) pubmed
- The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. (2019) pubmed
- Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies. (2021) pubmed
- Myo-inositol in assisted reproductive technology from bench to bedside. (2024) pubmed
- Production of myo-inositol: Recent advance and prospective. (2022) pubmed
- Myo-inositol in autoimmune thyroiditis, and hypothyroidism. (2018) pubmed